Type 1 and Type 2 diabetes are two different affections. Those with type 1 diabetes do not produce insulin, while those with type 2 do not produce enough insulin. Both are chronic diseases, and patients can develop several complications if they are not kept under control. Scotland will become the first country to offer C-peptide blood tests to patients diagnosed with Type 1 diabetes for at least three years and more.
How does the C-peptide blood test help?
This test shows the insulin levels produced by the patient’s body. Doctors can afterward diagnose the patient with type 1 or type 2 diabetes. This substance is produced in the pancreas at the same time as insulin. Therefore, if a patient has C-peptide, then that person might not have type 1 diabetes and might not need the daily injections.
A pilot study helped health experts understand the role of C-peptides
According to sources, a pilot study conducted by Prof Mark Strachan, diabetes and endocrinology expert, proved that C-peptide analysis helps medical providers offer a more accurate diagnosis. Scotland will provide the test at hospital diabetes centers hoping that its residents receive proper treatment and help for the type of diabetes they might have.
Common symptoms of diabetes
Some of the most common symptoms that might require a visit to your health provider include frequent urination, fatigue, blurry vision, cuts and bruises that do not heal easily, feeling hungry and thirsty, weight loss, and mood changes. A symptom of type 1 diabetes could be numbness and/or tingling in the hands and feet. Statistics show that over 276,000 people living in Scotland have diabetes, and by 2034 over 480,000 people might be living with this illness. Moreover, due to underlying health conditions, genetics, and age, over 5000,000 in Scotland have a high risk of developing type 2 diabetes in the future.
